Koers Integrative Health Technologies, Inc. Other OTC
Aandelen
IHTI
US45822A2078
Biotechnologie & Medisch Onderzoek
Omzet 2008 | 0,43 0,4 | Omzet 2009 | 0,45 0,41 | Marktkapitalisatie | 1,22 mln. 1,12 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2008 | - 0 | Nettowinst (verlies) 2009 | - 0 | EV/omzet 2008 | 14.379.727 x |
Nettoschuld 2008 | 99,02K 90,92K | Nettoschuld 2009 | 94,3K 86,58K | EV/omzet 2009 | 2.939.517 x |
K/w-verhouding 2008 |
231
x | K/w-verhouding 2009 |
31,6
x | Werknemers | - |
Dividendrendement 2008 * |
-
| Dividendrendement 2009 |
-
| Vrij verhandelbaar | 48,33% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Gilbert R. Kaats
CEO | Chief Executive Officer | - | - |
Samuel C. Keith
CIO | Chief Investment Officer | - | - |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Gilbert R. Kaats
CEO | Chief Executive Officer | - | - |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+29,77% | 49,18 mld. | |
+1,00% | 42,11 mld. | |
+50,47% | 40,37 mld. | |
-5,26% | 28,85 mld. | |
+13,68% | 26,09 mld. | |
-22,99% | 18,71 mld. | |
+8,22% | 13,26 mld. | |
+32,41% | 12,32 mld. | |
-1,62% | 11,99 mld. |